CLINICAL_TRIALS
trial_result
· 2026-04-13
Clinical Trial Update: Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris [Phase 2]
Summary
A Phase 2 study of NM8074 in adults with paroxysmal nocturnal hemoglobinuria (inadequate response to Soliris) is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NovelMed Therapeutics | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Status: NOT_YET_RECRUITING